01 1Emcure Pharmaceuticals
01 1METOCLOPRAMIDE HYDROCHLORIDE USP
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2018-09-10
Pay. Date : 2018-08-06
DMF Number : 32991
Submission : 2018-08-03
Status : Active
Type : II
20
Emcure Pharmaceuticals Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is METOCLOPRAMIDE HYDROCHLORIDE USP, with a corresponding US DMF Number 32991.
Remarkably, this DMF maintains an Active status since its submission on August 03, 2018, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of September 10, 2018, and payment made on August 06, 2018, indicating their dedication to facilitating drug approvals, Categorized as Type II
